Abstract:OBJECTIVE:Plasma free metanephrines (MNs) have been widely used as an initial test for pheochromocytoma and paraganglioma (PPGL). PPGL without MNs elevation has been reported on rare occasions. The objective of this study was to analyze the clinical profile of sporadic PPGL patients with normal MNs.METHODS:In the study, 104 patients with sporadic PPGL diagnosed by histopathology in Peking University First Hospital from March 2015 to January 2020 were enrolled. All the patients had plasma MNs result, of whom, eight (7.69%) were with normal MNs. The reasons for their medical visits, clinical manifestations, the levels of plasma free MNs, 3-methoxytyramine (3-MT), catecholamines and chromogranin A (CgA), and the imaging findings were documented. Their preoperative diagnosis, perioperative medical management, and intraoperative blood pressure were analyzed. All the data mentioned above were compared with the MNs elevated group. The postoperative follow-up for MNs normal patients were applied.RESULTS:For the eight PPGL patients with normal plasma MNs, the most common clinical symptoms were sweating (3/8), abdominal and back pain (3/8), headache (2/8), palpitations (2/8), and fatigue (2/8). There were no significant differences in plasma free 3-MT and catecholamines' diagnostic positive rate between the MNs normal group and MNs elevated group, but the rate for plasma CgA was significantly decreased in the MNs normal group (2/5 vs. 41/43, P=0.005). No significant difference was found for the incidence of typical findings by enhanced CT between the two groups. In these eight MNs normal patients, six were diagnosed with PPGL by the previous history of PPGL, typical symptoms and CT findings, or elevation of 3-MT, CgA levels or positive results of PET-CT; two patients were misdiagnosed as nonfunctioning adenoma or primary aldosteronism. All these MNs normal patients underwent preoperative management with alpha adrenergic receptor blockers, of whom, one had an average intraoperative arterial pressure < 60 mmHg during surgery. The median follow-up time for the eight patients was 1.5 (0.5－4.5) years. No evidence of new tumors was found on the enhanced CT scans. Two MNs normal patients' plasma 3-MT and (or) CgA decreased to normal.CONCLUSION:For patients with adrenal or retroperitoneal tumors, typical symptoms or a previous history of PPGL, normal plasma MNs is not a sufficient exclusion for PPGL. Plasma 3-MT, catecholamine, CgA results and the imaging findings are helpful for the diagnosis of PPGL. We recommend patients with suspected MNs normal PPGL take alpha adrenergic receptor blockers as preoperative blockade, but should avoid overdose. Postoperative follow-up for patients with normal MNs should focus on the positive biochemical markers before surgery.

Clinical diagnosis of pheochromocytoma and paraganglioma‐induced secondary hypertension through UPLC‐MS/MS analysis of plasma catecholamines and their metabolites

Detection of Plasma Catecholamines in Human Pheochromocytoma and Primary Hypertension Based on Liquid Chromatography Tandem Mass Spectrometry.

A 3-min UPLC-MS/MS method for the simultaneous determination of plasma catecholamines and their metabolites: Method verification and diagnostic efficiency

Plasma Metanephrine And Normetanephrine Measured By Lc-Ms/Ms In The Diagnosis Of Pheochromocytoma And Paraganglioma

[Clinical Profile of Pheochromocytoma and Paraganglioma with Normal Plasma Free Metanephrines].

Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites

The clinical feathers of phaechromocytoma and paraganglioma with normal plasmal free MNs

Simple, Rapid, and Cost-Effective Microextraction by the Packed Sorbent Method for Quantifying of Urinary Free Catecholamines and Metanephrines Using Liquid Chromatography-Tandem Mass Spectrometry and Its Application in Clinical Analysis.

Role of metanephrines, 3-methoxytyramine and chromogranin A in the diagnosis of PPGL

Clinical and Pathological Characteristics of Hypertensive and Normotensive Adrenal Pheochromocytomas.

Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy

Urinary free (unconjugated) metadrenalines in different hereditary forms of catecholamine-secreting phaeochromocytoma/paraganglioma

Update on clinical characteristics in the evaluation of phaeochromocytoma and paraganglioma

Glucose Disorders in Patients with Pheochromocytoma/Paraganglioma: Profile and influence effects in a large cohort with 705 patients

The diagnosis of pheochromocytoma by demonstrating elevated levels of catecholamines in the blood

Significance of Plasma Normetanephrine and Metanephrine in Diagnosis of Pheochromocytoma

Establishment a Diagnostic Strategy of Pheochromocytoma by Plasma Free Metanephrines Determined by Liquid Chromatography-Tandem Mass Spectrometry

ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Hypertension and Cardiac Damage in Pheochromocytoma and Paraganglioma Patients: a Large-Scale Single-Center Cohort Study

Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma

CARDIOVASCULAR AND METABOLIC PHENOTYPES OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA